Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Visningar
• 07/18/23
0
0
Bädda in
administrator
Prenumeranter
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna